Divangahi M - Search Results

1

Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.

Behr MA, Divangahi M, Schurr E. Behr MA, et al. Among authors: divangahi m. J Infect Dis. 2021 Feb 3;223(2):189-191. doi: 10.1093/infdis/jiaa637. J Infect Dis. 2021. PMID: 33535239 Free PMC article.

2

NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity.

Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, Veyrier F, Kobayashi KS, Flavell RA, Gros P, Behr MA. Divangahi M, et al. J Immunol. 2008 Nov 15;181(10):7157-65. doi: 10.4049/jimmunol.181.10.7157. J Immunol. 2008. PMID: 18981137

3

Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

Coulombe F, Divangahi M, Veyrier F, de Léséleuc L, Gleason JL, Yang Y, Kelliher MA, Pandey AK, Sassetti CM, Reed MB, Behr MA. Coulombe F, et al. Among authors: divangahi m. J Exp Med. 2009 Aug 3;206(8):1709-16. doi: 10.1084/jem.20081779. Epub 2009 Jul 6. J Exp Med. 2009. PMID: 19581406 Free PMC article.

4

What's in a name? The (mis)labelling of Crohn's as an autoimmune disease.

Behr MA, Divangahi M, Lalande JD. Behr MA, et al. Among authors: divangahi m. Lancet. 2010 Jul 17;376(9736):202-3. doi: 10.1016/S0140-6736(10)60282-6. Lancet. 2010. PMID: 20638565 No abstract available.

5

Vitamin D induces interleukin-1β expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection.

Verway M, Bouttier M, Wang TT, Carrier M, Calderon M, An BS, Devemy E, McIntosh F, Divangahi M, Behr MA, White JH. Verway M, et al. Among authors: divangahi m. PLoS Pathog. 2013;9(6):e1003407. doi: 10.1371/journal.ppat.1003407. Epub 2013 Jun 6. PLoS Pathog. 2013. PMID: 23762029 Free PMC article. Clinical Trial.

6

N-glycolylated peptidoglycan contributes to the immunogenicity but not pathogenicity of Mycobacterium tuberculosis.

Hansen JM, Golchin SA, Veyrier FJ, Domenech P, Boneca IG, Azad AK, Rajaram MV, Schlesinger LS, Divangahi M, Reed MB, Behr MA. Hansen JM, et al. Among authors: divangahi m. J Infect Dis. 2014 Apr 1;209(7):1045-54. doi: 10.1093/infdis/jit622. Epub 2013 Nov 21. J Infect Dis. 2014. PMID: 24265438

7

Freund's adjuvant, NOD2 and mycobacteria.

Behr MA, Divangahi M. Behr MA, et al. Among authors: divangahi m. Curr Opin Microbiol. 2015 Feb;23:126-32. doi: 10.1016/j.mib.2014.11.015. Epub 2014 Dec 5. Curr Opin Microbiol. 2015. PMID: 25483349 Review.

8

Tuberculosis.

Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC, Ginsberg A, Swaminathan S, Spigelman M, Getahun H, Menzies D, Raviglione M. Pai M, et al. Among authors: divangahi m. Nat Rev Dis Primers. 2016 Oct 27;2:16076. doi: 10.1038/nrdp.2016.76. Nat Rev Dis Primers. 2016. PMID: 27784885 Review.

9

Cracking the Vaccine Code in Tuberculosis.

Divangahi M, Behr MA. Divangahi M, et al. Am J Respir Crit Care Med. 2018 Feb 15;197(4):427-432. doi: 10.1164/rccm.201707-1489PP. Am J Respir Crit Care Med. 2018. PMID: 29045159 Review. No abstract available.

10

Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages.

Khan N, Divangahi M. Khan N, et al. Among authors: divangahi m. J Infect Dis. 2018 May 25;217(12):1851-1853. doi: 10.1093/infdis/jix626. J Infect Dis. 2018. PMID: 29432590 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page